Stock data

寶島科 (5312)

寶島科 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$371.29M, up 6.5% from a year earlier. EPS over the last four quarters totals NT$7.32.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 寶島科 in Insightr